Načítá se...
Heart Transplant Survival Outcomes for Adriamycin Dilated Cardiomyopathy
In 2015 there will be an estimated 11.3 million cancer survivors. With a growing population of cancer survivors, it is imperative to understand treatment options and outcomes for chemotherapy related cardiomyopathy. Anthracycline (AC) based chemotherapy causes heart failure (HF) in approximately 5%...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3563750/ https://ncbi.nlm.nih.gov/pubmed/23195041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2012.10.048 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|